Antisense modulation of survivin expression

Details for Australian Patent Application No. 2001236581 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Cowsert, Lex M; Swayze, Eric E; Ackermann, Elizabeth J; Bennett, C. Frank

Agent FB Rice

Pub. Number AU-B-2001236581

PCT Pub. Number WO01/57059

Priority 09/496,694 02.02.00 US

Filing date 30 January 2001

Wipo publication date 14 August 2001

Acceptance publication date 24 June 2004

International Classifications

C07H 021/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12N 015/00 Mutation or genetic engineering

C12N 015/09 Mutation or genetic engineering - Recombinant DNA-technology

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

24 June 2004 Application Accepted

  Published as AU-B-2001236581

21 October 2004 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001236582

2001236580